Search Results - "Matory, Y L"

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2 by Lotze, MT, Matory, YL, Ettinghausen, SE, Rayner, AA, Sharrow, SO, Seipp, CA, Custer, MC, Rosenberg, SA

“…Purified recombinant human interleukin 2 (RIL 2) derived from E. coli containing the inserted gene encoding for IL 2 was administered to 20 patients with a…”
Get full text

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer by Rosenberg, S A, Lotze, M T, Muul, L M, Leitman, S, Chang, A E, Ettinghausen, S E, Matory, Y L, Skibber, J M, Shiloni, E, Vetto, J T

“…We describe here the preliminary results of the systemic administration of autologous lymphokine-activated killer (LAK) cells and the recombinant-derived…”
Get more information

Esophagogastrectomy: reoperation for complications by Matory, Y L, Burt, M

“…From 1961 to 1991, a total of 1,452 esophagectomies were performed for esophageal cancer at Memorial Sloan-Kettering Cancer Center. Of these patients, 40…”
Get more information

Clinical effects and toxicity of interleukin-2 in patients with cancer by Lotze, M T, Matory, Y L, Rayner, A A, Ettinghausen, S E, Vetto, J T, Seipp, C A, Rosenberg, S A

“…Interleukin-2 (IL-2) is a 15,000 dalton glycoprotein produced naturally by human T-cells during an immune response. IL-2 has been demonstrated to have…”
Get more information

Magnetic resonance imaging Versus computed tomography in the evaluation of soft tissue tumors of the extremities by CHANG, A. E, MATORY, Y. L, ROSENBERG, S. A, DWYER, A. J, HILL, S. C, GIRTON, M. E, STEINBERG, S. M, KNOP, R. H, FRANK, J. A, HYAMS, D, DOPPMAN, J. L

“…Twenty patients with extremity soft tissue tumors were prospectively evaluated with magnetic resonance imaging (MRI) and computed tomography (CT) scans with…”
Get full text

Wound bleeding after head and neck surgery by Matory, Y L, Spiro, R H

“…Using our head and neck service database, we reviewed 3,200 surgical procedures performed at our institution over a 7-year period. We identified 54 patients…”
Get more information

Carcinoma of the ampulla of Vater by Matory, Y L, Gaynor, J, Brennan, M

“…We reviewed our experience with 69 patients with carcinoma of the ampulla of Vater admitted to the Memorial Sloan-Kettering Cancer Center, New York, from…”
Get more information

The diagnosis and treatment of breast cancer by Matory, Y L

“…There have been several new developments in breast cancer research. Investigators are closer to identifying the breast cancer gene, which may aid in the…”
Get more information

Hepaticportoenterostomy as surgical therapy for biliary atresia by Matory, Y L, Miyano, T, Suruga, K

“…The Kasai I and Suruga I procedures are the most commonly reported surgical procedures used for the correction of biliary atresia. Clinical results are similar…”
Get more information

The toxicity of recombinant human interleukin-2 in rats following intravenous infusion by Matory, Y L, Chang, A E, Lipford, 3rd, E H, Braziel, R, Hyatt, C L, Rosenberg, S A

“…Studies of recombinant interleukin-2 (RIL-2) administered by continuous intravenous infusion revealed hepatocellular toxicity and redistribution of lymphoid…”
Get full text

Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfected mouse mammary tumor by Matory, Y L, Dorfman, D M, Wu, L, Chen, M, Goedegebuure, P, Eberlein, T J

“…We have performed TNF-alpha gene transfection in a mouse mammary cancer line and found significant antitumor effects. We hypothesize that the antitumor effects…”
Get more information

Classification of CD4+ T helper cell clones in human melanoma by Goedegebuure, P S, Lee, K Y, Matory, Y L, Peoples, G E, Yoshino, I, Eberlein, T J

“…We have previously described the generation of tumor-infiltrating lymphocyte (TIL) clones from renal cell cancer by solid-phase anti-CD3 antibody activation…”
Get more information

T cells mediate treatment of six-day-old cytokine-gene-transfected mouse mammary tumor by Matory, Y L, Dorfman, D M, Chen, M, Wu, L, Spanjaard, R A, Goedegebuure, P S, Eberlein, T J

“…We have previously shown that immunologically different mouse mammary cancer cell lines induce antitumor responses after IL2 or IL4 gene transfection. We now…”
Get more information

Toxicity of recombinant human interleukin-2 in rats following intravenous infusion by Matory, Y L, Chang, A E, Lipford, 3rd, E H, Braziel, R, Hyatt, C L, McDonald, H D, Rosenberg, S A

“…The recent availability of recombinant human interleukin-2 (RIL-2) has increased interest in the potential clinical use of this lymphokine. We have examined…”
Get more information

Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection by Matory, Yvedt L., Chen, Man, Dorfman, David M., Williams, Amanda, Goedegebuure, Peter S., Eberlein, Timothy J.

“…Background. The antitumor effects of three mouse mammary tumors transfected to express interferon-γ were evaluated. Methods. Three immunologically different…”
Get full text

Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumors by Matory, Y L, Chen, M, Goedegebuure, P S, Eberlein, T J

“…The anti-tumor effects of three mouse mammary tumors transfected to express interleukin (IL) 2 or 4 were evaluated. Three immunologically different tumors were…”
Get full text

Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection. Discussion by MATORY, Y. L, MAN CHEN, DORFMAN, D. M, WILLIAMS, A, GOEDEGEBUURE, P. S, EBERLEIN, T. J, ECONOMOU, J. S, KIM, B, BEAR, H. D, HOLDER, W. D

Get full text

In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta. Discussion by PEPLINSKI, G. R, KANGLA TSUNG, MEKO, J. B, NORTON, J. A, GRAHAM, L. M, BEN KIM, DRAZAN, K. E, MATORY, Y. L, HUTH, J. F

Get full text